• 1
    Alonso EM, Superina RA, Whitington PF. Fulminant hepatitis and acute liver failure. In: KellyDA, ed. Diseases of the Liver and Biliary System in Children. London: Blackwell Science Ltd., 1999: 7794.
  • 2
    Sherlock S, Dooley J. Fulminant hepatic failure. In: SherlockS, DooleyJ, eds. Diseases of the Liver and Biliary System. London: Blackwell Science Ltd., 1997: 103117.
  • 3
    Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. HEPATOLOGY 1995; 21: 240252.
  • 4
    Lee WM. Acute liver failure. N Engl J Med 1993; 329: 18621872.
  • 5
    Riegler JL, Lake JR. Fulminant hepatic failure. Med Clin North Am 1993; 77: 10571083.
  • 6
    Schiodt FV, Atillasoy E, Shakil O, Schiff ER, Caldwell C, Kowdley KV, Stribling R, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 2934.
  • 7
    Acharya SK, Dasarathy S, Kumer TJ, Sushma S, Prasanna KS, Tandon A, Sreenivas V, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. HEPATOLOGY 1996; 23: 14481455.
  • 8
    Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986; 6: 97106.
  • 9
    Liu CJ, Kao JH, Lai MY, Chen PJ, Chu JS, Chen W, Chen DS. Minimal role of GB virus-C/Hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan. J Gastroenterol Hepatol 1999; 14: 352357.
  • 10
    Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1987; 111: 3439.
  • 11
    Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. HEPATOLOGY 1986; 6: 648651.
  • 12
    O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439445.
  • 13
    Sung JL, Chen DS, Lai MY, Yu JY, Wang TH, Wang CY, Lee CY, et al. Epidemiological study of hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1984; 1: 19.
  • 14
    Chen DS, Sung JL. Hepatitis B virus infection in Taiwan. N Engl J Med 1977; 297: 668669.
  • 15
    Chang MH, Chen DS, Hsu HC, Hsu HY, Lee CY. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989; 64: 23772380.
  • 16
    Ni YH, Chang MH, Hsu HY, Hsu HC, Chen CC, Chen WJ, Lee CY. Hepatocellular carcinoma in childhood: clinical manifestations and prognosis. Cancer 1991; 68: 17371741.
  • 17
    Sung JL, Chen DS. Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan. Scand J Gastroenterol 1980; 15: 321324.
  • 18
    Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations. HEPATOLOGY 1982; 2: 21S26S.
  • 19
    Vanclaire J, Cornu C, Sokal EM. Fulminant hepatitis B in an infant born to a hepatitis Be-antibody positive, DNA-negative mother. Arch Dis Child 1991; 66: 983985.
  • 20
    Beath SV, Boxall EH, Watson RM, Tarlow MJ, Kelly DA. Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. BMJ 1992; 304: 11691170.
  • 21
    Shimizu H, Mitsuda T, Fujita S, Yokota S. Perinatal hepatitis B virus infection caused by anti-hepatitis B e-positive maternal mononuclear cells. Arch Dis Child 1991; 66: 718721.
  • 22
    Chen DS, Hsu HM, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 257: 25972603.
  • 23
    Hsu HM, Chen DS, Chuang CH. Efficacy of a mass hepatitis B vaccination program in Taiwan: studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 1988; 260: 22312235.
  • 24
    Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in Taipei, 1984: a study just before a mass hepatitis B vaccination program in Taiwan. J Med Virol 1986; 18: 301307.
  • 25
    Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991; 34: 9699.
  • 26
    Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906908.
  • 27
    Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, et al. Hepatitis B virus infection in children and adolescents in an hyperendemic area: 15 years after universal hepatitis B vaccination. Ann Intern Med 2001; 135: 796800.
  • 28
    Chang MH, Chen CJ, Lai MS, Hsu HM, Wu CT, Kong MS, Liang DC, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 18551859.
  • 29
    Lai MW, Chang MH, Hsu HY. Non-A, non-B, non-C hepatitis: its significance in pediatric patients and the role of GB virus-C. J Pediatr 1997; 131: 536540.
  • 30
    Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001; 139: 349352.
  • 31
    Chen DS, Hsu HM, Bennett CL, Pajeau TS, Blumberg B, Chang PY, Nishioka K, et al. A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program. Cancer Causes Control 1996; 7: 305311.
  • 32
    Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999; 179: 367370.
  • 33
    Rosner B. Hypothesis testing: person-time data. In: RosnerB, ed. Fundamentals of Biostatistics. 5th edition. Pacific Grove, CA: Duxbury Press, 2000: 682690.
  • 34
    Dupuy JM, Kostewicz E, Alagille D. Hepatitis B in children. I. Analysis of 80 cases of acute and chronic hepatitis B. J Pediatr 1978; 92: 1720.
  • 35
    Rosh JR, Schwersenz AH, Groisman G, Benkov KJ, LeLeiko NS. Fatal fulminant hepatitis B in an infant despite appropriate prophylaxis. Arch Pediatr Adolesc Med 1994; 148: 13491351.
  • 36
    Lee CY, Huang LM, Chang MH, Hsu CY, Wu SJ, Sung JL, Safary A. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. Pediatr Infect Dis J 1991; 10: 299303.
  • 37
    Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih HH, et al. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediatr Infect Dis J 2003; 22: 584588.
  • 38
    Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: OkudaK, IsahkKG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987: 119.
  • 39
    Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, Liang DC, Hsu HM, et al., Taiwan Childhood Hepatoma Study Group. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000; 284: 30403042.